Ultrasound and antibodies — a potentially powerful combination for Alzheimer disease therapy
Authors:
- 20 February 2024
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 20 (5) , 257-258
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s DiseaseNew England Journal of Medicine, 2024
- Clinical relevance of animal models in aging-related dementia researchNature Aging, 2023
- Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD modelTranslational Neurodegeneration, 2022
- Low-intensity ultrasound restores long-term potentiation and memory in senescent mice through pleiotropic mechanisms including NMDAR signalingMolecular Psychiatry, 2021
- A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer diseaseAlzheimer's Research & Therapy, 2021
- Applications of focused ultrasound in the brain: from thermoablation to drug deliveryNature Reviews Neurology, 2020
- Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse modelScience Translational Medicine, 2015
- Open questions for Alzheimer’s disease immunotherapyAlzheimer's Research & Therapy, 2014
- Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in RabbitsRadiology, 2001
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999